VANCOUVER, British Columbia, Aug. 17, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: NetApp (NASDAQ:NTAP), Idenix (NASDAQ:IDIX), Juniper Networks (NYSE:JNPR), Home Depot (NYSE:HD), Melco Crown Entertainment (NASDAQ:MPEL), and Celgene (NASDAQ:CELG).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
NetApp, Inc. (NASDAQ:NTAP): NetApp Inc. (NASDAQ:NTAP) announced on August 15 that in 2013 fiscal quarter ended July 27, its revenue came in as the company had expected at US$1.45 billion, about the same as last year's report of US$1.46 billion in the same period last year. In the first fiscal quarter of 2013, GAAP net income was US$64 million (or US$0.17 per share), compared to last year's report of income of US$140 million (or US$0.34 per share). Non-GAAP net income also came in as the company expected, at US$156 million. "NetApp produced non-GAAP earnings per share above and revenue in line with our prior guidance. In Q1, we announced further innovations in Data ONTAP 8.1 that will enable customers to achieve an agile data infrastructure environment to cope with their dynamic business requirements," said president Tom Georgens. "We continue to deliver on multiple fronts, advancing our technology and partnerships." However, company officials are still reporting insider trades with the SEC. In the last three months, company insiders have sold US$749,230 worth of stock. Are NetApp insiders starting to take huge profits by selling shares or exercising stock options? Add NTAP into your watch list for insider trade now.
Read Full Report: http://www.insiderslab.com/PR3/081712A/NTAP/NetApp.pdf
Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX): Shares of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) dumped US$2.47 (or -29.72%) to US$5.84 on hefty volume of 19.17 million shares, which was 11 times more than usual. Idenix is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. On August 16, the company announced that it received verbal notice from the U.S. Food and Drug Administration (FDA) that a partial clinical hold has been placed on IDX184, which is the company's nucleotide polymerase inhibitor under development for the treatment of hepatitis C virus (HCV). For the second quarter ended June 30, 2012, Idenix reported total revenues rose 40% to US$1.4 million, from US$1.0 million in the same quarter of 2011. Net loss for the second quarter was US$25.4 million (or US$0.23 per basic and diluted share), compared with a net loss of US$13.9 million (or US$0.15 per basic and diluted share) for the prior-year quarter. Did Idenix insiders like CEOs, CFOs, and Directors sell their shareholdings before the stock price dropped? Academic studies have shown that company insiders traditionally make higher investment returns than ordinary investors. Do you want to know when Idenix insiders will purchase their shares? Check out the insider trade report here.
Read Full Report: http://www.insiderslab.com/PR3/081712A/IDIX/Idenix.pdf
Juniper Networks, Inc. (NYSE:JNPR): Insiderslab.com found Market Sale made by company Independent Director -- William R. Stensrud on August 7, at stock price US$19.10. Disclose date: August 9. By market close, shares of Juniper Networks, Inc. (NYSE:JNPR) ended higher by 0.81% to US$18.59 on over 9.92 million shares, compared to its average volume of 10.45 million shares. The company has a market capitalization of US$9.84 billion with price range within US$14.01 - US$25.60 over the past 52 weeks. Insiderslab.com refers insider trading data to professional investors as it believes that Juniper Networks insiders have a better understanding about the company's prospects. Do you want to know when Juniper Networks insiders will buy their shares?
Read Full Report: http://www.insiderslab.com/PR3/081712A/JNPR/JuniperNetworks.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
The Home Depot, Inc. (NYSE:HD):
Read Full Report: http://www.insiderslab.com/PR3/081712A/HD/HomeDepot.pdf
Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL):
Read Full Report: http://www.insiderslab.com/PR3/081712A/MPEL/MelcoCrownEntertainment.pdf
Celgene Corporation (NASDAQ:CELG):
Read Full Report: http://www.insiderslab.com/PR3/081712A/CELG/Celgene.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
SOURCE Insiderslab.com; Insiders.hk